|1.||Oyeyipo, Ibukun P: 1 article (01/2010)|
|2.||Femi-Akinlosotu, Omowunmi: 1 article (01/2010)|
|3.||Akinola, Adeniran: 1 article (01/2010)|
|4.||Raji, Yinusa: 1 article (01/2010)|
|5.||Majumdar, Subrata: 1 article (02/2009)|
|6.||Pal, Amita: 1 article (02/2009)|
|7.||Mukherjee, Asok: 1 article (02/2009)|
|8.||Bhattacharjee, Surajit: 1 article (02/2009)|
|9.||Bhattacharya, Parna: 1 article (02/2009)|
|10.||Mujumdar, Suchandra Bhattacharyya: 1 article (02/2009)|
|1.||Body Weight (Weight, Body)
01/01/2010 - "Groups V, VI and VII rats were also treated orally with 0.1 mg/kg, 1.0mg/kg and 2.0 mg/kg body weight of quassin for 60 days but were left untreated for another 30 days, to serve as the recovery groups. "
01/01/2010 - "Group I served as the control group and received distilled water while Groups II, III and IV rats were treatedorally with 0.1mg/kg, 1.0 mg/kg and 2.0 mg/kg body weight of quassin for 60 days respectively. "
01/01/2008 - "Quassin at doses up to 2.0 g/kg in drinking water using rats produced no significant effect on the body weights, but the mean weights of the testes, seminal vesicles, and epididymides were significantly reduced, and the weights of the anterior pituitary glands were significantly increased. "
02/01/2009 - "The effect of quassin on the production of Th1 cytokines such as interleukin (IL)-12 and tumour necrosis factor (TNF)-alpha and Th2 cytokines such as IL-10 and transforming growth factor-beta was measured by ELISA, and the mRNA expression of these cytokines was analysed by real-time PCR. "
|1.||Interleukin-10 (Interleukin 10)
|2.||Transforming Growth Factor beta (TGF-beta)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|5.||Messenger RNA (mRNA)
|6.||Monoamine Oxidase (MAO)